Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

5.9K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

4.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.5K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

2.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

3.1K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
3.1K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

3.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ketamine Low dOse Evaluation on morphine consumption in traumatic patients: study protocol for a randomized, double-blind, placebo-controlled trial (KLOE-Trial).

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

International evidence-based recommendations for point-of-care lung ultrasound : 2025 focused update of the 2012 recommendations.

Intensive care medicine·2026
Same author

Comparative 30-day life cycle assessment of bladder drainage strategies.

BJU international·2026
Same author

The environmental footprint and ecotoxicity of sevoflurane and propofol anaesthesia: a retrospective observational modelling study.

British journal of anaesthesia·2026
Same author

Determinants of Septic Shock and 90-Day Mortality After Postoperative Healthcare-Associated Intra-Abdominal Infection: The Sepsi-Pop Study, a Multicenter Retrospective Study.

Shock (Augusta, Ga.)·2026
Same author

Musculoskeletal injury research in sub-Saharan Africa : a ten-year bibliometric analysis of research outputs from Malawi, South Africa, and Tanzania.

Bone & joint open·2026
Same journal

Epinephrine nebulization delays need for life-saving intervention following smoke inhalation in ovine model.

Shock (Augusta, Ga.)·2026
Same journal

Sodium-Glucose Cotransporter 2 Inhibitors as Discharge Medications in Survivors of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Shock (Augusta, Ga.)·2026
Same journal

Dynamic Temperature Modeling Predicts Mortality in Murine Sepsis.

Shock (Augusta, Ga.)·2026
Same journal

Changes of Intestinal Aquaporins after Experimental Polytrauma and Hemorrhagic Shock: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Effect of Chest Compression Release Velocity on Cerebral Perfusion Pressure in a Porcine Cardiac Arrest Model: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Ulinastatin Treatment Associated with Lower Sepsis-Associated Encephalopathy Risk in Sepsis Patients: A Multicenter Observational Study.

Shock (Augusta, Ga.)·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Restraint to Induce Stress in Mice and Rats
03:48

Restraint to Induce Stress in Mice and Rats

Published on: December 6, 2024

4.1K

NOREPINEPHRINE: NOT TOO MUCH, TOO LONG.

Claude Martin1, Sophie Medam, François Antonini

  • 1Service d'Anesthésie et de Réanimation, Hôpital Nord, Assistance Publique Hôpitaux de Marseille, and Aix Marseille Université, Marseille, France.

Shock (Augusta, Ga.)
|July 1, 2015
PubMed
Summary
This summary is machine-generated.

High norepinephrine dosages (over 1 μg/kg/min) in septic shock patients are linked to a 90% mortality rate. Other mortality factors include older age, low platelets, and reduced urine output.

More Related Videos

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

10.5K
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

15.5K

Related Experiment Videos

Last Updated: Apr 8, 2026

Restraint to Induce Stress in Mice and Rats
03:48

Restraint to Induce Stress in Mice and Rats

Published on: December 6, 2024

4.1K
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

10.5K
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

15.5K

Area of Science:

  • Critical Care Medicine
  • Pharmacology
  • Epidemiology

Background:

  • Septic shock is a life-threatening condition requiring intensive care.
  • Norepinephrine is a common vasopressor used in septic shock management.
  • The relationship between high-dose norepinephrine and mortality requires further investigation.

Purpose of the Study:

  • To assess the association between high-dose norepinephrine and mortality in septic shock patients.
  • To determine the specific norepinephrine dosage linked to a >90% intensive care unit (ICU) death rate.

Main Methods:

  • Retrospective, observational study of 324 septic shock patients in a single academic ICU.
  • Data collected on patient demographics, norepinephrine dosage, and clinical parameters.
  • Mortality assessed at ICU discharge, hospital discharge, and 90 days post-admission.

Main Results:

  • Overall 48% mortality rate in the septic shock cohort.
  • Norepinephrine dosage exceeding 1 μg/kg/min was associated with a 90% mortality rate.
  • Independent mortality predictors included older age, thrombocytopenia, low urine output (<500 mL), and high-dose norepinephrine.

Conclusions:

  • High-dose norepinephrine (>1 μg/kg/min) is strongly associated with increased mortality in septic shock.
  • Age, thrombocytopenia, and reduced urine output are also significant independent predictors of mortality.
  • Findings suggest careful monitoring and dose titration of norepinephrine in septic shock patients.